1-3 of 3
Yuki Katsura
Close
Sort by
Journal Articles

Efficient Generation of HLA-A24-Restricted WT1-Specific Cytotoxic T Lymphocytes Using Gene-Engineered Artificial Antigen-Presenting Cells

Masahiro Ogasawara, MD, Ph.D, Tomohiro Yamakawa, MD, Yuki Katsura, MD, Kanako Shima, MD, Toshihiro Matsukawa, MD, Minoru Kanaya, MD, Koichiro Minauchi, MD, Masanobu Nakata, MD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, Ph.D, Teiichi Hirano, MD, Ph.D, Naoki Kobayashi, MD, Ph.D, Yoshio Kiyama, MD, Naoto Hirano, MD, Ph.D
Journal: Blood
Blood (2010) 116 (21): 2101.
https://doi.org/10.1182/blood.V116.21.2101.2101
Published: 2010
Journal Articles

Imatinib Mesylate Impairs the Function of Human Regulatory T Cells (Tregs) and Reverses the Inhibition of Immune Responses to Imatinib-Resistant CML Cells by Tregs.

Masahiro Ogasawara, Toshihiro Matsukawa, Yuki Katsura, Kanako Shima, Minoru Kanaya, Mizuha Kosugi, Satomi Matsuoka, Shiro Fujii, Shinsuke Noguchi, Shuichi Ota, MD, PhD, Masanobu Nakata, MD, Kiyotoshi Imai, Teiichi Hirano, Naoki Kobayashi, Yoshio Kiyama, MD, Masaharu Kasai, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4728.
https://doi.org/10.1182/blood.V114.22.4728.4728
Published: 2009
Journal Articles

Pre-Treatment Serum Soluble Interleukin-2 Receptor Value Significantly Predicts Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma.

Shinsuke Noguchi, MD, Masanobu Nakata, MD, Kanako Shima, MD, Yuki Katsura, MD, Toshihiro Matsukawa, MD, Minoru Kanaya, MD, Satomi Matsuoka, MD, Mizuha Kosugi, MD, Shiro Fujii, MD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, PhD, Teiichi Hirano, MD, PhD, Naoki Kobayashi, MD, PhD, Masahiro Ogasawara, MD, PhD, Yoshio Kiyama, MD, Masaharu Kasai, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3948.
https://doi.org/10.1182/blood.V114.22.3948.3948
Published: 2009